Edesa Biotech Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -14.2% | -17.3% | -19.3% | -27.0% | +9.2% | +295.1% | -10.0% | -7.7% | +7.7% | -15.8% | +2.7% | |
| – | -15.9% | -21.7% | -28.2% | -45.0% | +23.7% | +594.4% | -11.3% | -9.8% | +10.5% | -18.1% | +3.5% | |
| – | -20.4% | -34.4% | -27.1% | -49.2% | +50.7% | +788.8% | -11.0% | -12.7% | +11.7% | -17.0% | +3.3% | |
| – | -20.4% | -34.4% | -27.1% | -49.2% | +50.7% | +788.8% | -11.0% | -12.7% | +11.7% | -17.0% | +3.3% | |
| – | +18.7% | +49.6% | -50.5% | -50.8% | +29.4% | +9.1% | -25.0% | +124.2% | -32.9% | -49.8% | +5.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.2% | -1.2% | -1.2% | -1.2% | -1.2% | -1.2% | -1.2% | -1.3% | -1.3% | -1.3% | -1.3% | |
| – | -4.2% | +8.2% | +9.8% | -22.4% | +3.7% | -51.9% | -26.5% | +79.8% | -37.5% | +189.3% | +78.7% | |
| – | +9.1% | +8.2% | +9.8% | -22.4% | +3.7% | -51.9% | -26.5% | +60.3% | -29.9% | +189.3% | +78.7% | |
| – | +4.8% | -25.8% | -33.2% | -48.8% | – | – | – | – | – | – | – | |
| – | +9.2% | +109,539.5% | +11.0% | -21.9% | +4.8% | -51.9% | -26.5% | – | – | – | – | |
| – | -17.1% | -26.0% | -33.7% | -30.9% | +14.3% | +586.4% | -9.1% | -11.9% | +12.1% | -26.9% | -13.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.3% | +2.1% | +0.9% | +0.8% | +3.0% | +58.6% | +32.4% | +0.5% | +13.0% | +7.1% | +5.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.